Market Size and Overview Global preclinical assets market size is valued at US$ 5,250.2 million in 2022 and is expected to witness a CAGR of 7.5% over the forecast period (2022 – 2030). Robust market growth is propelled by rising R&D expenditure across pharmaceutical and biotech firms, coupled with evolving regulatory frameworks that increase demand for well-characterized preclinic... https://hallbook.com.br/blogs/769286/Preclinical-Assets-Market-Size-and-Trends-Shaping-Growth-in-2042